Cargando…

Interferon-α2b Treatment for COVID-19

The global pandemic of COVID-19 cases caused by infection with SARS-CoV-2 is ongoing, with no approved antiviral intervention. We describe here the effects of treatment with interferon (IFN)-α2b in a cohort of confirmed COVID-19 cases in Wuhan, China. In this uncontrolled, exploratory study, 77 adul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Qiong, Chen, Virginia, Shannon, Casey P., Wei, Xiao-Shan, Xiang, Xuan, Wang, Xu, Wang, Zi-Hao, Tebbutt, Scott J., Kollmann, Tobias R., Fish, Eleanor N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242746/ https://www.ncbi.nlm.nih.gov/pubmed/32574262 http://dx.doi.org/10.3389/fimmu.2020.01061

Ejemplares similares

Corrigendum: Interferon-α2b Treatment for COVID-19
por: Zhou, Qiong, et al.
Publicado: (2020)

Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities
por: Zhou, Qiong, et al.
Publicado: (2020)

Omicron variants of SARS-CoV-2 and long COVID
por: Yang, Chengliang, et al.
Publicado: (2022)

Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways
por: Mazewski, Candice, et al.
Publicado: (2020)

Machine Learning-Based Single Cell and Integrative Analysis Reveals That Baseline mDC Predisposition Correlates With Hepatitis B Vaccine Antibody Response
por: Aevermann, Brian D., et al.
Publicado: (2021)

Interferon β-1a ring prophylaxis to reduce household transmission of SARS-CoV-2: a cluster randomised clinical trial
por: Castro-Rodriguez, José A., et al.
Publicado: (2023)

Multi-Omic Data Integration Allows Baseline Immune Signatures to Predict Hepatitis B Vaccine Response in a Small Cohort
por: Shannon, Casey P., et al.
Publicado: (2020)

Role of epigenetic modification in interferon treatment of hepatitis B virus infection
por: Yang, Zhijing, et al.
Publicado: (2022)

Immunotherapy With Interferon α11, But Not Interferon Beta, Controls Persistent Retroviral Infection
por: Schwerdtfeger, Mara, et al.
Publicado: (2022)

Interferon-α-Enhanced CD100/Plexin-B1/B2 Interactions Promote Natural Killer Cell Functions in Patients with Chronic Hepatitis C Virus Infection
por: He, Yu, et al.
Publicado: (2017)

The yin and yang of viruses and interferons
por: Wang, Ben X., et al.
Publicado: (2012)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
por: Wittling, Megen C., et al.
Publicado: (2021)

Variation between Populations in the Innate Immune Response to Vaccine Adjuvants
por: Kollmann, Tobias R.
Publicado: (2013)

Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Karamitros, Timokratis, et al.
Publicado: (2018)

Global virus outbreaks: Interferons as 1st responders
por: Wang, Ben X., et al.
Publicado: (2019)

Characterization of the antiviral effects of interferon-α against a SARS-like coronoavirus infection in vitro
por: Zorzitto, Joanna, et al.
Publicado: (2006)

Understanding the Ontogeny of the Immune System to Promote Immune-Mediated Health for Life
por: Marchant, Arnaud, et al.
Publicado: (2015)

Interferon and Hepatitis B: Current and Future Perspectives
por: Ye, Jianyu, et al.
Publicado: (2021)

Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24(+)CD38(hi) B Cells
por: Fu, Binqing, et al.
Publicado: (2020)

Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study
por: Xu, Nan, et al.
Publicado: (2022)

Induction of immunoproteasomes in porcine kidney (PK)-15 cells by interferon-γ and tumor necrosis factor-α
por: LIU, Qiang, et al.
Publicado: (2019)

Interferon and interferon-stimulated genes in HBV treatment
por: Li, Qirong, et al.
Publicado: (2022)

Balancing the Risks and Benefits of COVID-19 Vaccination for Pregnant Women and Their Children
por: Yang, Chengliang, et al.
Publicado: (2021)

Evolution of Interferons and Interferon Receptors
por: Secombes, Chris J., et al.
Publicado: (2017)

A Novel Type-I Interferon Family, Bovine Interferon-Chi, Is Involved in Positive-Feedback Regulation of Interferon Production
por: Guo, Yongli, et al.
Publicado: (2020)

Interferon-α Subtypes As an Adjunct Therapeutic Approach for Human Immunodeficiency Virus Functional Cure
por: George, Jeffy, et al.
Publicado: (2018)

The Role of Environmental Factors in Modulating Immune Responses in Early Life
por: MacGillivray, Duncan M., et al.
Publicado: (2014)

Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis
por: Song, Aixin, et al.
Publicado: (2021)

Type I Interferon Regulates the Survival and Functionality of B Cells in Rainbow Trout
por: Benedicenti, Ottavia, et al.
Publicado: (2020)

Type I Interferons in Bacterial Infections: A Balancing Act
por: Kovarik, Pavel, et al.
Publicado: (2016)

Fish Paralog Proteins RNASEK-a and -b Enhance Type I Interferon Secretion and Promote Apoptosis
por: Sun, Zhi-Chao, et al.
Publicado: (2021)

Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis
por: Fan, Shuang, et al.
Publicado: (2023)

Preparing for Life: Plasma Proteome Changes and Immune System Development During the First Week of Human Life
por: Bennike, Tue Bjerg, et al.
Publicado: (2020)

The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis
por: Roff, Shannon R., et al.
Publicado: (2014)

Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-α-accelerated lupus nephritis in mice
por: Chen, Kuan-Ju, et al.
Publicado: (2023)

TLR3 Ligand PolyI:C Prevents Acute Pancreatitis Through the Interferon-β/Interferon-α/β Receptor Signaling Pathway in a Caerulein-Induced Pancreatitis Mouse Model
por: Huang, Chaohao, et al.
Publicado: (2019)

Changes of natural killer cells’ phenotype in patients with chronic hepatitis B in intermittent interferon therapy
por: Bi, Xiaoyue, et al.
Publicado: (2023)

Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus
por: Akita, Kanae, et al.
Publicado: (2021)

Neutralizing Anti-Cytokine Autoantibodies Against Interferon-α in Immunodysregulation Polyendocrinopathy Enteropathy X-Linked
por: Rosenberg, Jacob M., et al.
Publicado: (2018)

Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients
por: Contoli, Marco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9p2qg18vas86dq2fdkh89ielkr